Allergan and Editas Medicine Initiate the Brilliance Phase 1/2 Clinical Trial of AGN-151587 (EDIT-101) for the Treatment of LCA10

July 25, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search